Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics, automation, modelling, process optimization and other digital tools to transform the available information into actionable insights.
The global digital manufacturing market size is anticipated to reach at USD 2.0 billion in 2024 to 12.30 billion by 2035, to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period, till 2035.
The modernization of the biomanufacturing process has been more visible and successful as a result of the recent breakthroughs in the data analytics and data science. Innovative technologies, such as AI and digital twins, have become part of an important strategy for biopharmaceutical companies to future-proof their business operations and address various issues, including growing expenses, stringent regulatory guidelines and deteriorating profit margins.
Type of Technology
Process Analytical Technology(PAT)
Data Analysis Software(DAS)
Manufacturing Execution Systems(MES)
Digital Twins
Deployment Options
Cloud-based
On-premises
Type(s) of Biologic(s)Manufactured
Antibodies
Cell and Gene Therapies
Proteins
Vaccines
Others
The growing preference for digitalization of bioprocessing is evident from the rise in partnership activity; it is worth highlighting that more than 80% of the deals were forged in the last three years. Over the past few years, players engaged in the digital biomanufacturing domain have entered into various agreements, in order to expand and diversify their respective portfolios. Further, there has been a steady increase in the number of agreements signed by players in this domain. Key companies engaged in digital manufacturing industry are AspenTech, Bioreactors.net, Dassault Systèmes, FUJIFILM Diosynth Biotechnologies, GE Healthcare, Körber, Merck, Sartorius and Thermo Fisher Scientific.
The current market landscape features the presence of over 104 digital biomanufacturing providers offering over 140 different types of platforms, based on PAT, DAS, MES, digital twins. Further, process analytical technologies (52) captures the maximum share of the digital biomanufacturing market, followed by manufacturing execution systems (34), data analysis software (17) and digital twins (11). Moreover, the market for PAT providers is currently dominated by the presence of small players (20), followed by mid-sized firms (13). It is worth highlighting that 35% of small companies were established post-2015 that are spearheading the innovation in this domain. Notable examples include (in reverse chronological order of their establishment) GenSensor (2021), Qubicon (2020), KYNOTA (2020) and Xenomics (2020).
In fact, most of the PAT-based platforms engaged in digital biomanufacturing are capable of performing process automation (90%), followed by bioprocess optimization and controls (86%) and process connectivity solutions (81%). It is worth highlighting that 16% of technologies are capable of offering more than six platform capabilities. Notable examples include (in alphabetical order) MARTA (developed by Bionet), CellPort POWR (developed by CellPort), and Zenon (developed by Copa Data).
Most of the companies engaged in this domain offer on-premises deployment option (52%), followed by those providing cloud-based deployment option (40%). It is important to highlight that 21% of the firms offering cloud-based services for biomanufacturing are emerging start-ups that are established post-2015. Further, most of the companies engaged in this domain offer PAT platforms that facilitate the manufacturing of proteins (53%), followed by antibodies (42%) and cell therapies (26%). Notable examples of platforms offering protein manufacturing services include (in alphabetical order) Apollo X (developed by FUJIFILM Diosynth Biotechnologies), Integrated Continuous Bioprocessing (developed by Transcenta), MiD ProteinID (developed by Microsaic Systems) and SYMPHONX (developed by FUJIFILM Diosynth Biotechnologies).
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Digital Manufacturing Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To request free sample report click on the following link
www.rootsanalysis.com/reports/digital-biomanufacturing-market.html